New compound HPH-15 offers promising alternative to diabetes medications

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes treatment innovation.

Madrigal’s $600M offering; PureTech to return $100M to shareholders

Plus, news about Outlook Therapeutics, Geron, Fate Therapeutics, Enliven Therapeutics, Seelos and Portal Biotechnologies: Madrigal Pharmaceuticals’s $600M offering: The company is raising money to boost

March 20, 2024

Notice of Auction and Sale of Receivership Property – Cannabis

Gene R. Kohut of Trust Street Advisors, LLC in his capacity as court-appointed receiver (the “Receiver”) of Green Peak Industries, Inc., District Bay, LLC, The

July 5, 2023

Biotech Stocks Second Quarter Outlook • Prudent Biotech

Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A

April 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.